Context Therapeutics Inc.
$28.8 M
Initial Public Offering
Sole Book-Runner
Harbor Custom Development, Inc
$41.4 M
8% Series A Cumulative Convertible Preferred Stock
Sole Book-Runner
EzFill Holdings, Inc.
$28.8 M
IPO
Sole Book-Runner
Virpax Pharmaceuticals, Inc.
$40 M
Follow-On Offering
Sole Book-Runner
authID.ai
$11.5 M
Follow-On Offering
Sole Book-Runner
ProPhase Labs, Inc.
$14.6 M
Acquisition of Nebula Genomics
Advisor
PetVivo Holdings, Inc.
$11.3 M
Follow-On Offering
Sole Book-Runner
BioVie Inc.
$20 M
Follow-On Offering
Sole Book-Runner
Draganfly Inc.
$20 M
Follow-On Offering
Sole Book-Runner
Opportunity Financial, LLC and FG New America Acquisition Corp.
$800 M
Business Combination
Capital Markets Advisor
Twin Vee PowerCats Co.
$18 M
IPO
Sole Book-Runner
Red Cat Holdings, Inc.
$60 M
Follow-On Offering
Sole Book-Runner